Shanghai Fosun Pharmaceutical (Group) (SFOSF) News Today

$1.70
+0.10 (+6.27%)
(As of 05/17/2024 ET)
Is Ardelyx is A Buy After Slip in Early 2022 (SFOSF)
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them
Get Shanghai Fosun Pharmaceutical (Group) News Delivered to You Automatically

Sign up to receive the latest news and ratings for SFOSF and its competitors with MarketBeat's FREE daily newsletter.

Bill Gates is all about this tiny $2 stock (Ad)

What does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…

>>Click here to discover why Bill Gates is all about this tiny $2 stock.

SFOSF Media Mentions By Week

SFOSF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SFOSF
News Sentiment

0.00

0.42

Average
Medical
News Sentiment

SFOSF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SFOSF Articles
This Week

0

0

SFOSF Articles
Average Week

Get Shanghai Fosun Pharmaceutical (Group) News Delivered to You Automatically

Sign up to receive the latest news and ratings for SFOSF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:SFOSF) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners